![]() ![]() It is widely believed that VED therapy is more acceptable among elderly patients with occasional sexual intimacy, as younger patients may show limited acceptance because of its perceived “unnatural” erection. It is used when pharmacotherapies have failed and in patients with stable relationship. The vacuum erectile device (VED) uses negative pressure to increase blood inflow into the corpora cavernosum, with a ring at the base of the penis to maintain erection for intercourse or without a ring for penile rehabilitation. When first line therapy with phosphodiesterase type 5 (PDE5) inhibitors is ineffective or contraindicated, patients should be offered other non-surgical treatment choices such as intracavernous injection therapy, intraurethral alprostadil and vacuum constriction devices. There is no special protocol for treatment of ED in diabetic patients other than in the treatment of ED in general population. It is clear that microangiopathy of the cavernosal artery, corporal veno-occlusive dysfunction and autonomic neuropathy are the primary pathophysiological pathways for ED. The primary mechanism that links increased risk of ED to diabetes is suggested to be vascular and neural. It is already known that diabetes mellitus (DM) is a well-established risk factor for ED and that ED affects 50% overall and 30% of treated diabetics. It should not be regarded only as a quality of life (QoL) issue, but also as a potential warning sign of cardiovascular disease. VED could be a good alternative therapy for patients who denied peroral therapy.Įrectile dysfunction (ED) is defined as the consistent or recurrent inability to attain and maintain a penile erection sufficient for sexual intercourse. Patients with DM type I had more serious risk for development of arteriogenic ED. There was significant improvement in three items of IIEF after six months of treatment among both groups of examinees. Also, DCA showed significant difference between two groups of patients. ![]() Significantly higher values of PSV were obtained in patients with DM type II. Alprostadil injection test was also used, with Doppler color flow imaging system, to evaluate the peak systolic velocity (PSV) and diameter of cavernosal artery (DCA). The International Index of Erectile Function (IIEF) was used to quantify erectile dysfunction. Patients were using VED and six months later were assessed for therapy results. Study enrolled 50 males with DM, aged from 35 to 67 years, who have attended the urologic clinic due to inability to attain and maintain an erection of the penis sufficient to permit satisfactory sexual intercourse. The aim of this study is to investigate changes in the vascular system and hemodynamics between patients with organic erectile dysfunction (ED) (DM type I and II), as well as to compare the quality of sexual life between those two groups after the treatment with vacuum erection device (VED).
0 Comments
Leave a Reply. |